Development of Grade II Acute Graft-versus-Host Disease Is Associated with Improved Survival after Myeloablative HLA-Matched Bone Marrow Transplantation using Single-Agent Post-Transplant Cyclophosphamide. uri icon

authors

  • Shannon R. McCurdy, MD
  • Swinnen, Lode J
  • Huff, Carol Ann
  • Brodsky, Robert A
  • Ambinder, Richard F
  • Fuchs, Ephraim J
  • Rosner, Gary L
  • Jones, Richard J
  • Luznik, Leo
  • Kanakry, Christopher G
  • Tsai, Hua-Ling
  • Gojo, Ivana
  • Smith, B Douglas
  • Gladstone, Douglas E
  • Bolaños-Meade, Javier
  • Borrello, Ivan
  • Matsui, William H

publication date

  • December 30, 2018